1116333

Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany — FEI 2211084

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Whippany, NJ (United States)